Novartis (NVS) is due to appear before India's Supreme Court on Wednesday in an attempt to gain patent protection for its leading cancer-drug Glivec, which the Indian government declined to provide. The case comes as India, although suffering from a slowing economy and high inflation, becomes increasingly unpredictable and unfriendly for foreign companies.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Fri, 9:00AM)
at Zacks.com (Tue, 4:13PM)
at Investor's Business Daily (Feb 23, 2015)
at Benzinga.com (Feb 23, 2015)
at Investor's Business Daily (Jan 26, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs